Triglycerides and HDL cholesterol: stars or second leads in diabetes?

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S373-7. doi: 10.2337/dc09-S343.
No abstract available

Publication types

  • Review

MeSH terms

  • Atherosclerosis / blood
  • Atherosclerosis / epidemiology
  • Atherosclerosis / mortality
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / mortality
  • Cholesterol, HDL / blood*
  • Coronary Disease / blood
  • Coronary Disease / epidemiology
  • Coronary Disease / mortality
  • Diabetes Complications / blood*
  • Diabetes Complications / drug therapy
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / mortality
  • Diabetic Angiopathies / blood*
  • Diabetic Angiopathies / drug therapy
  • Dyslipidemias / blood
  • Fatty Acids, Omega-3 / therapeutic use
  • Humans
  • Niacin / therapeutic use
  • PPAR alpha / agonists
  • Stroke / blood
  • Stroke / epidemiology
  • Stroke / mortality
  • Triglycerides / blood*

Substances

  • Cholesterol, HDL
  • Fatty Acids, Omega-3
  • PPAR alpha
  • Triglycerides
  • Niacin